DULUTH, Ga., May 7, 2018 /PRNewswire/ -- Sebacia, Inc., a privately held dermatology and aesthetics company, today announceda precedential ruling from the U.S. Court of Appeals for the Federal Circuit. The ruling relates to a patent interference proceeding between The General Hospital Corporation (GHC, the owner of certain patents licensed by Sebacia) and Sienna Biopharmaceuticals,
Anthony Lando, CEO of Sebacia, commented, "We are pleased with the outcome of this precedential decision by the Federal Circuit, and we look forward to further proceedings within the PTAB focused on determining first to invent."
The referenced case is General Hospital Corp. v. Sienna Biopharmaceuticals Inc., case number 17-1012, in the U.S. Court of Appeals for the Federal Circuit.
Sebacia, Inc. is a private medical device company dedicated to creating breakthrough topical therapies for the treatment of dermatological conditions affecting millions of people. Sebacia's goal is to provide a better alternative to the daily use of topical and systemic drugs currently available for the treatment of acne. Sebacia's patented microparticles technology was invented at Rice University, and the proprietary dermatology applications were further developed with researchers from the Wellman Center of Photomedicine at Massachusetts General Hospital. Sebacia is located in Duluth, Georgia.
More information is available at www.sebacia.com or follow us at www.twitter.com/SebaciaNews.
View original content:http://www.prnewswire.com/news-releases/sebacia-announces-favorable-ruling-by-us-court-of-appeals-for-the-federal-circuit-regarding-patent-interference-proceedings-with-sienna-biopharmaceuticals-inc-300643753.html
SOURCE Sebacia, Inc.
Subscribe to our Free Newsletters!
FDA approved elapegademase-lvlr injection for intramuscular use is used as an enzyme replacement ...
Armpit lumps and raised bumps in the armpits caused by infection, cysts and other types of ...
Bad eating habits will affect your health as well as your skin and make you look older than your ...View All